Patients continuing initial and any antidepressant medication: fluoxetine (Flu) v desipramine (Des) and imipramine (Imi)‡

Outcomes at 12 moComparisonContinuation ratesRBI (95% CI)NNT (CI)
Continuing initial medicationFlu v Des42% v 20%107% (43 to 201)5 (4 to 10)
Flu v Imi42% v 27% 56% (13 to 117)7 (4 to 25)
RBR (CI)NNH
‡RBR = relative benefit reduction. Other abbreviations defined in glossary; RBI, RBR, NNT, NNH, and CI calculated from data supplied by author.
Continuing any medicationFlu v Des51% v 54%6.8% (−16 to 25)Not significant
Flu v Imi51% v 50%1.4% (−28 to 19)Not significant